Levothyroxine Recall: Thyro-Tabs 150mcg
Announced 2026-01-21 · FDA
A recall has been issued for Thyro-Tabs Levothyroxine Sodium Tablets, 150 mcg, 1000 tablets, Rx only. A single bottle of this lot reportedly contained 88 mcg tablets instead of 150 mcg due to a product mix-up. The recalled lot is Lot MHA21825 with expiration date December 31, 2027, distributed nationwide in the US.
| Brand | Alvogen, Inc |
|---|---|
| Product | Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10. |
| Reason | Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets. |
| Severity | moderate |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any tablets from Lot MHA21825.
- Contact your pharmacist or healthcare provider about replacement or refund.
- Return the product to the pharmacy or distributor as instructed.
- If you have questions or experience symptoms, seek medical advice.
How to identify the recalled item
| Lot / date codes | Lot # MHA21825, Exp Date: December 31, 2027 |
|---|---|
| Lot / date codes | Lot # MHA21825, Exp Date: December 31, 2027 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other levothyroxine recalls
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.